Log In
BCIQ
Print this Print this
 

IONIS-FVIIRX (formerly ISIS-FVIIRX)

  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionAntisense compound that inhibits Factor VII
Molecular Target Factor VIIa
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsTreat clotting disorders
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today